A cocktail of thermally stable, chemically synthesized capture agents for the efficient detection of anti-gp41 antibodies from human sera

PLoS One. 2013 Oct 7;8(10):e76224. doi: 10.1371/journal.pone.0076224. eCollection 2013.

Abstract

We report on a method to improve in vitro diagnostic assays that detect immune response, with specific application to HIV-1. The inherent polyclonal diversity of the humoral immune response was addressed by using sequential in situ click chemistry to develop a cocktail of peptide-based capture agents, the components of which were raised against different, representative anti-HIV antibodies that bind to a conserved epitope of the HIV-1 envelope protein gp41. The cocktail was used to detect anti-HIV-1 antibodies from a panel of sera collected from HIV-positive patients, with improved signal-to-noise ratio relative to the gold standard commercial recombinant protein antigen. The capture agents were stable when stored as a powder for two months at temperatures close to 60(o)C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antibodies, Anti-Idiotypic / immunology
  • Click Chemistry / methods
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes / immunology
  • HIV Antibodies / blood
  • HIV Antibodies / immunology*
  • HIV Envelope Protein gp41 / immunology*
  • HIV Infections / blood
  • HIV Infections / diagnosis
  • HIV Infections / immunology
  • HIV Seropositivity / diagnosis
  • HIV Seropositivity / immunology*
  • HIV Seropositivity / virology
  • Humans
  • Molecular Structure
  • Peptides / chemical synthesis
  • Peptides / chemistry
  • Peptides / immunology*
  • Protein Binding / immunology
  • Protein Stability
  • Signal-To-Noise Ratio
  • Temperature

Substances

  • Antibodies, Anti-Idiotypic
  • Epitopes
  • HIV Antibodies
  • HIV Envelope Protein gp41
  • Peptides
  • gp41 protein, Human immunodeficiency virus 1

Grants and funding

This work was funded primarily by a grant from the Bill and Melinda Gates Foundation. Additional funding for the development of screening approaches, and for certain capture agent characterization methods, was provided by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.